From: Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition
aHV | SPARE-AD | HCI | PC-FDG-PET | T-tau | P-tau181 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
(+) | (−) | (+) | (−) | (+) | (−) | (+) | (−) | (+) | (−) | ||
aHV | 66.0% | 34.0% | 56.4% | 43.6% | 66.1% | 33.9% | 60.4% | 39.6% | 55.75% | 44.25% | |
SPARE-AD | 0.06 | 68.5% | 31.5% | 50.7% | 49.3% | 79.0% | 21.0% | 45.3% | 54.7% | ||
HCI | 0.05 | 0.05 | 64.5% | 45.5% | 63.6% | 36.4% | 46.0% | 54.0% | |||
PC-FDG-PET | 0.33 | 0.03 | 0.10 | 50.8% | 49.2% | 51.0% | 49.0% | ||||
T-tau | 0.06 | 0.04 | 0.11 | 0.07 | 63.6% | 36.4% | |||||
P-tau 181 | 0.15 | 0.0 | −0.01 | −0.05 | 0.31 |